On the public citation graph

Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation

0 signed · 135 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ddr.21762openalex-snapshot
Review of registered clinical trials for the treatment of COVID‐19
inferredcites →https://doi.org/10.1002/med.21728openalex-snapshot
COVID‐19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays
inferredcites →https://doi.org/10.1002/minf.202000113openalex-snapshot
QSAR Modeling of SARS‐CoV M pro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2
inferredcites →https://doi.org/10.1007/978-0-387-84858-7openalex-snapshot
The Elements of Statistical Learning: Data Mining, Inference, and Prediction
inferredcites →https://doi.org/10.1007/s00210-020-01901-6openalex-snapshot
A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)
inferredcites →https://doi.org/10.1007/s00705-020-04693-5openalex-snapshot
The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review
inferredcites →https://doi.org/10.1007/s11095-020-02851-7openalex-snapshot
Repurposing of Kinase Inhibitors for Treatment of COVID-19
inferredcites →https://doi.org/10.1016/bs.armc.2020.02.001openalex-snapshot
Anticancer natural products
inferredcites →https://doi.org/10.1016/j.arcmed.2020.06.004openalex-snapshot
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
inferredcites →https://doi.org/10.1016/j.bj.2020.11.011openalex-snapshot
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
inferredcites →https://doi.org/10.1016/j.bsheal.2021.02.001openalex-snapshot
An update to monoclonal antibody as therapeutic option against COVID-19
inferredcites →https://doi.org/10.1016/j.cegh.2020.07.006openalex-snapshot
Antivirals for COVID-19: A critical review
inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
inferredcites →https://doi.org/10.1016/j.cell.2020.04.026openalex-snapshot
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
inferredcites →https://doi.org/10.1016/j.cell.2020.06.034openalex-snapshot
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
inferredcites →https://doi.org/10.1016/j.csbj.2021.06.017openalex-snapshot
WADDAICA: A webserver for aiding protein drug design by artificial intelligence and classical algorithm
inferredcites →https://doi.org/10.1016/j.ebiom.2020.103104openalex-snapshot
Persistence of Viral RNA, Pneumocyte Syncytia and Thrombosis Are Hallmarks of Advanced COVID-19 Pathology
inferredcites →https://doi.org/10.1016/j.idcr.2020.e00864openalex-snapshot
Doxycycline as a potential partner of COVID-19 therapies
inferredcites →https://doi.org/10.1016/j.immuni.2020.04.003openalex-snapshot
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
inferredcites →https://doi.org/10.1016/j.isci.2020.101303openalex-snapshot
Current Status of COVID-19 Therapies and Drug Repositioning Applications
inferredcites →https://doi.org/10.1016/j.jcv.2020.104362openalex-snapshot
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
inferredcites →https://doi.org/10.1016/j.jiph.2020.07.013openalex-snapshot
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
inferredcites →https://doi.org/10.1016/j.meegid.2020.104610openalex-snapshot
A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection
inferredcites →https://doi.org/10.1016/j.placenta.2012.07.016openalex-snapshot
ABC drug transporter and nuclear receptor expression in human cytotrophoblasts: Influence of spontaneous syncytialization and induction by glucocorticoids
inferredcites →https://doi.org/10.1016/j.ymeth.2021.08.007openalex-snapshot
Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
inferredcites →https://doi.org/10.1016/s1574-1400(08)00012-1openalex-snapshot
PubChem: Integrated Platform of Small Molecules and Biological Activities
inferredcites →https://doi.org/10.1016/s2214-109x(20)30444-7openalex-snapshot
COVID-19 pneumonia and the appropriate use of antibiotics
inferredcites →https://doi.org/10.1021/jm301916bopenalex-snapshot
Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis
inferredcites →https://doi.org/10.1021/jm5019093openalex-snapshot
PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
inferredcites →https://doi.org/10.1023/a:1006313611677openalex-snapshot
UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell Lines
inferredcites →https://doi.org/10.1038/d41573-020-00073-5openalex-snapshot
The COVID-19 vaccine development landscape
inferredcites →https://doi.org/10.1038/d41586-021-00268-9openalex-snapshot
Novavax offers first evidence that COVID vaccines protect people against variants
inferredcites →https://doi.org/10.1038/d41586-021-00785-7openalex-snapshot
What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine
inferredcites →https://doi.org/10.1038/nbt.4314openalex-snapshot
Dimensionality reduction for visualizing single-cell data using UMAP
inferredcites →https://doi.org/10.1038/nprot.2009.97openalex-snapshot
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
inferredcites →https://doi.org/10.1038/s41392-021-00558-8openalex-snapshot
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development
inferredcites →https://doi.org/10.1038/s41416-020-0948-xopenalex-snapshot
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
inferredcites →https://doi.org/10.1038/s41421-020-00221-6openalex-snapshot
Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients
inferredcites →https://doi.org/10.1038/s41467-018-05116-5openalex-snapshot
Network-based approach to prediction and population-based validation of in silico drug repurposing
inferredcites →https://doi.org/10.1038/s41467-020-15562-9openalex-snapshot
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
inferredcites →https://doi.org/10.1038/s41586-020-2286-9openalex-snapshot
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
inferredcites →https://doi.org/10.1038/s41586-020-2649-2openalex-snapshot
Array programming with NumPy
inferredcites →https://doi.org/10.1038/s41586-021-03491-6openalex-snapshot
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
inferredcites →https://doi.org/10.1038/s41586-021-03944-yopenalex-snapshot
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
inferredcites →https://doi.org/10.1038/s41598-019-53239-6openalex-snapshot
The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy
inferredcites →https://doi.org/10.1038/s41598-020-70143-6openalex-snapshot
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
inferredcites →https://doi.org/10.1038/s41598-020-73641-9openalex-snapshot
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
inferredcites →https://doi.org/10.1038/s41598-021-86002-xopenalex-snapshot
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
inferredcites →https://doi.org/10.1038/s41598-021-91625-1openalex-snapshot
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
inferredcites →https://doi.org/10.1038/sj.leu.2401994openalex-snapshot
Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies
inferredcites →https://doi.org/10.1038/srep25694openalex-snapshot
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
inferredcites →https://doi.org/10.1073/pnas.0506580102openalex-snapshot
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
inferredcites →https://doi.org/10.1080/07391102.2020.1794971openalex-snapshot
Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants
inferredcites →https://doi.org/10.1093/bib/bbaa288openalex-snapshot
A review on drug repurposing applicable to COVID-19
inferredcites →https://doi.org/10.1093/bib/bbaa417openalex-snapshot
Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment
inferredcites →https://doi.org/10.1093/bib/bbx017openalex-snapshot
A review of network-based approaches to drug repositioning
inferredcites →https://doi.org/10.1093/bioinformatics/btaa030openalex-snapshot
BMDx: a graphical Shiny application to perform Benchmark Dose analysis for transcriptomics data
inferredcites →https://doi.org/10.1093/bioinformatics/btg405openalex-snapshot
affy—analysis of Affymetrix GeneChip data at the probe level
inferredcites →https://doi.org/10.1093/bioinformatics/bti525openalex-snapshot
BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis
inferredcites →https://doi.org/10.1093/bioinformatics/btv536openalex-snapshot
Drug-set enrichment analysis: a novel tool to investigate drug mode of action
inferredcites →https://doi.org/10.1093/bioinformatics/bty063openalex-snapshot
INfORM: Inference of NetwOrk Response Modules
inferredcites →https://doi.org/10.1093/femspd/ftaa036openalex-snapshot
Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19)
inferredcites →https://doi.org/10.1093/gigascience/giaa055openalex-snapshot
TinderMIX: Time-dose integrated modelling of toxicogenomics data
inferredcites →https://doi.org/10.1093/nar/gkaa1027openalex-snapshot
Open Targets Platform: supporting systematic drug–target identification and prioritisation
inferredcites →https://doi.org/10.1093/nar/gkj067openalex-snapshot
DrugBank: a comprehensive resource for in silico drug discovery and exploration
inferredcites →https://doi.org/10.1093/nar/gku955openalex-snapshot
Open TG-GATEs: a large-scale toxicogenomics database
inferredcites →https://doi.org/10.1093/nar/gkv951openalex-snapshot
PubChem Substance and Compound databases
inferredcites →https://doi.org/10.1093/nar/gkx1037openalex-snapshot
DrugBank 5.0: a major update to the DrugBank database for 2018
inferredcites →https://doi.org/10.1093/nar/gng015openalex-snapshot
Summaries of Affymetrix GeneChip probe level data
inferredcites →https://doi.org/10.1093/toxsci/kfm092openalex-snapshot
A Method to Integrate Benchmark Dose Estimates with Genomic Data to Assess the Functional Effects of Chemical Exposure
inferredcites →https://doi.org/10.1099/jgv.0.001047openalex-snapshot
Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors
inferredcites →https://doi.org/10.1101/2020.04.21.054387openalex-snapshot
Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2
inferredcites →https://doi.org/10.1101/gr.124321.111openalex-snapshot
Differential expression in RNA-seq: A matter of depth
inferredcites →https://doi.org/10.1109/iccv.2017.322openalex-snapshot
Mask R-CNN
inferredcites →https://doi.org/10.1111/j.2517-6161.1995.tb02031.xopenalex-snapshot
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
inferredcites →https://doi.org/10.1111/pai.13271openalex-snapshot
The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures
inferredcites →https://doi.org/10.1126/science.1132939openalex-snapshot
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
inferredcites →https://doi.org/10.1126/science.abd2985openalex-snapshot
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
inferredcites →https://doi.org/10.1126/science.abg5827openalex-snapshot
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
inferredcites →https://doi.org/10.1126/sciimmunol.abd0110openalex-snapshot
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
inferredcites →https://doi.org/10.1128/jvi.00975-21openalex-snapshot
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
inferredcites →https://doi.org/10.1128/jvi.79.21.13800-13805.2005openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus Fails To Activate Cytokine-Mediated Innate Immune Responses in Cultured Human Monocyte-Derived Dendritic Cells
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-2602openalex-snapshot
The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial
inferredcites →https://doi.org/10.1158/2159-8290.cd-rw2019-179openalex-snapshot
The C-Terminal Domain of SMARCB1 Mediates Chromatin Remodeling
inferredcites →https://doi.org/10.1182/blood-2005-08-3351openalex-snapshot
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
inferredcites →https://doi.org/10.1186/1471-2105-9-461openalex-snapshot
minet: A R/Bioconductor Package for Inferring Large Transcriptional Networks Using Mutual Information
inferredcites →https://doi.org/10.1186/1471-2164-8-387openalex-snapshot
BMDExpress: a software tool for the benchmark dose analyses of genomic data
inferredcites →https://doi.org/10.1186/1758-2946-5-30openalex-snapshot
Drug repositioning: a machine-learning approach through data integration
inferredcites →https://doi.org/10.1186/gb-2010-11-10-r106openalex-snapshot
Differential expression analysis for sequence count data
inferredcites →https://doi.org/10.1186/s13054-020-03120-0openalex-snapshot
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
inferredcites →https://doi.org/10.1186/s13059-014-0550-8openalex-snapshot
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
inferredcites →https://doi.org/10.1186/s13321-015-0069-3openalex-snapshot
Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
inferredcites →https://doi.org/10.1214/aos/1013203451openalex-snapshot
Greedy function approximation: A gradient boosting machine.
inferredcites →https://doi.org/10.1371/journal.pbio.0050008openalex-snapshot
Large-Scale Mapping and Validation of Escherichia coli Transcriptional Regulation from a Compendium of Expression Profiles
inferredcites →https://doi.org/10.1515/sagmb-2014-0093openalex-snapshot
TopKLists: a comprehensive R package for statistical inference, stochastic aggregation, and visualization of multiple omics ranked lists
inferredcites →https://doi.org/10.1524/auto.2011.0951openalex-snapshot
Simulation physiologischer Regelkreise mit der objektorientierten Modellbibliothek “HumanLib”
inferredcites →https://doi.org/10.15252/embj.2020106267openalex-snapshot
Syncytia formation by SARS‐CoV‐2‐infected cells
inferredcites →https://doi.org/10.15252/embj.2020107405openalex-snapshot
Erratum To: Syncytia formation by SARS‐CoV‐2‐infected cells
inferredcites →https://doi.org/10.15252/embj.2021107821openalex-snapshot
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
inferredcites →https://doi.org/10.21203/rs.3.rs-23951/v1openalex-snapshot
Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection
inferredcites →https://doi.org/10.2147/dddt.s282252openalex-snapshot
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
inferredcites →https://doi.org/10.25080/majora-92bf1922-00aopenalex-snapshot
Data Structures for Statistical Computing in Python
inferredcites →https://doi.org/10.26434/chemrxiv.12115251openalex-snapshot
Drug Repurposing of Approved Drugs Elbasvir, Ledipasvir, Paritaprevir, Velpatasvir, Antrafenine and Ergotamine for Combating COVID19
inferredcites →https://doi.org/10.31219/osf.io/7hgpjopenalex-snapshot
Is Fostamatinib a possible drug for COVID-19? – A computational study
inferredcites →https://doi.org/10.3389/fcell.2020.545089openalex-snapshot
Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
inferredcites →https://doi.org/10.3389/fphar.2020.01196openalex-snapshot
COVID-19 Therapeutic Options Under Investigation
inferredcites →https://doi.org/10.4018/ijqspr.20200701.oa1openalex-snapshot
Principles of QSAR Modeling
inferredcites →https://doi.org/10.4081/monaldi.2020.1300openalex-snapshot
COVID-19 and coagulative axis: review of emerging aspects in a novel disease
inferredcites →https://doi.org/10.48550/arxiv.1201.0490openalex-snapshot
Scikit-learn: Machine Learning in Python
inferredcites →https://doi.org/10.48550/arxiv.1208.3145openalex-snapshot
Metric distances derived from cosine similarity and Pearson and Spearman correlations
inferredcites →https://doi.org/10.7759/cureus.10480openalex-snapshot
Therapeutic Options for COVID-19: A Review

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1007/978-3-031-78728-7_9openalex-snapshot
Introduction to Multiscale Modeling for One Health Approaches
inferred← citeshttps://doi.org/10.1007/s00239-025-10249-5openalex-snapshot
Evolutionary and Structural Assessment of the Human Secreted Frizzled-Related Protein (SFRP) Family
inferred← citeshttps://doi.org/10.1016/b978-0-443-15339-6.00011-4openalex-snapshot
Integrated modeling for compound efficacy and safety assessment
inferred← citeshttps://doi.org/10.1016/j.csbj.2022.03.014openalex-snapshot
Nextcast: A software suite to analyse and model toxicogenomics data
inferred← citeshttps://doi.org/10.1016/j.csbj.2022.08.061openalex-snapshot
The potential of a data centred approach & knowledge graph data representation in chemical safety and drug design
inferred← citeshttps://doi.org/10.1021/acsptsci.3c00317openalex-snapshot
Screening Peptide Drug Candidates To Neutralize Whole Viral Agents: A Case Study with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
inferred← citeshttps://doi.org/10.1038/s41597-023-02321-wopenalex-snapshot
A curated gene and biological system annotation of adverse outcome pathways related to human health
inferred← citeshttps://doi.org/10.1073/pnas.2210990119openalex-snapshot
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein
inferred← citeshttps://doi.org/10.1080/07391102.2023.2239932openalex-snapshot
Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics
inferred← citeshttps://doi.org/10.1101/2023.10.22.563490openalex-snapshot
Screening Peptide Drug Candidates to Neutralize Whole Viral Agents : A Case study with SARS-CoV-2 Virus
inferred← citeshttps://doi.org/10.1186/s12967-024-04879-4openalex-snapshot
Integrative network analysis suggests prioritised drugs for atopic dermatitis
inferred← citeshttps://doi.org/10.30906/0869-2092-2022-85-7-13-22openalex-snapshot
Фармакологические вещества, проявляющие противовирусную активность в отношении коронавируса SARS-CoV-2
inferred← citeshttps://doi.org/10.3389/fphar.2021.755600openalex-snapshot
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
inferred← citeshttps://doi.org/10.3390/app13031522openalex-snapshot
An Update of Carbazole Treatment Strategies for COVID-19 Infection
inferred← citeshttps://doi.org/10.3390/cancers14082043openalex-snapshot
Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study
inferred← citeshttps://doi.org/10.3390/jcm11154464openalex-snapshot
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
inferred← citeshttps://doi.org/10.3390/molecules28186603openalex-snapshot
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/ph15111333openalex-snapshot
Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
inferred← citeshttps://doi.org/10.3390/ph16060834openalex-snapshot
A Tale of Two Proteases: MPro and TMPRSS2 as Targets for COVID-19 Therapies
inferred← citeshttps://doi.org/10.6084/m9.figshare.26668452openalex-snapshot
Additional file 1 of Integrative network analysis suggests prioritised drugs for atopic dermatitis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26668455openalex-snapshot
Additional file 2 of Integrative network analysis suggests prioritised drugs for atopic dermatitis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26668458openalex-snapshot
Additional file 3 of Integrative network analysis suggests prioritised drugs for atopic dermatitis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26668461openalex-snapshot
Additional file 4 of Integrative network analysis suggests prioritised drugs for atopic dermatitis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26668464openalex-snapshot
Additional file 5 of Integrative network analysis suggests prioritised drugs for atopic dermatitis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.